Assignee
ALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC
US·10 granted patents·6 pending applications·7 citations·filing 2013–2025
Top patents by PatentIndex Score
16 records- 0182US9737472B2Light-absorbing compositions and methods of useALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·2 cites·8 claims
- 0276US10435711B2Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNAALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2018·Granted Oct 8, 2019·1 cites·14 claims
- 0374US2025051726A1Induction of neural progenitor cells, oligodendrocyte progenitor cells, and oligodendrocytes by stem cell differentiation using landmark transcription factorsALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0474US2024002909A1Use of enzymes for altering ratios of partially matched polynucleotidesALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0573US10119150B2Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNAALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2014·Granted Nov 6, 2018·1 cites·20 claims
- 0669US10155929B2Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNAALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2013·Granted Dec 18, 2018·2 cites·6 claims
- 0767US2025283047A1Induction of pancreatic beta cells by stem cell differentiation with rnaALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0864US2020087712A1Use of enzymes for altering ratios of partially matched polynucleotidesALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0959US12104171B2Induction of neural progenitor cells, oligodendrocyte progenitor cells, and oligodendrocytes by stem cell differentiation using landmark transcription factorsALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2018·Granted Oct 1, 2024·0 cites·14 claims
- 1057US10221221B2Monomeric yellow-green fluorescent protein from cephalochordateALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2013·Granted Mar 5, 2019·1 cites·5 claims
- 1155US12338462B2Induction of pancreatic beta cells by stem cell differentiation with RNAALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2017·Granted Jun 24, 2025·0 cites·9 claims
- 1254US2019233482A1Novel monomeric yellow-green fluorescent protein from cephalochordateALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1347US2022195403A1Methods of achieving high specificity of genome editingALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1444US12404552B2Methods of selecting antibodies and antibody fragmentsALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2016·Granted Sep 2, 2025·0 cites·19 claims
- 1541US12559729B2Induction of hepatocytes by stem cell differentiation with RNAALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2017·Granted Feb 24, 2026·0 cites·22 claims
- 1640US10842728B2Light-absorbing compositions and methods of useALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC·Filed 2017·Granted Nov 24, 2020·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when ALLELE BIOTECHNOLOGY & PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →